Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xinhong Sun"'
Autor:
Weiwei Lin, Rui Niu, Seong-Min Park, Yan Zou, Sung Soo Kim, Xue Xia, Songge Xing, Qingshan Yang, Xinhong Sun, Zheng Yuan, Shuchang Zhou, Dongya Zhang, Hyung Joon Kwon, Saewhan Park, Chan Il Kim, Harim Koo, Yang Liu, Haigang Wu, Meng Zheng, Heon Yoo, Bingyang Shi, Jong Bae Park, Jinlong Yin
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Glioblastoma stem-like cells (GSCs) contribute to therapeutic resistance and recurrence of glioblastomas. Here the authors show that Insulin-like Growth Factor-Binding Protein 5 (IGFBP5) is a ligand for Receptor tyrosine kinase-like Orphan Receptor 1
Externí odkaz:
https://doaj.org/article/0337cd4391ed4b818834807eddf4d75a
Autor:
Yufeng Shou, Xin Yong Teo, Xianlei Li, Le Zhicheng, Ling Liu, Xinhong Sun, Win Jonhson, Jun Ding, Chwee Teck Lim, Andy Tay
Publikováno v:
ACS Nano. 17:2851-2867
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43869d7cb8a89dc44ece3bedd168a525
https://doi.org/10.1021/acsnano.2c11278
https://doi.org/10.1021/acsnano.2c11278
Autor:
Yan Zou, Xinhong Sun, Qingshan Yang, Meng Zheng, Olga Shimoni, Weimin Ruan, Yibin Wang, Dongya Zhang, Jinlong Yin, Xiangang Huang, Wei Tao, Jong Bae Park, Xing-Jie Liang, Kam W. Leong, Bingyang Shi
We designed a unique nanocapsule for efficient single CRISPR-Cas9 capsuling, noninvasive brain delivery and tumor cell targeting, demonstrating an effective and safe strategy for glioblastoma gene therapy. Our CRISPR-Cas9 nanocapsules can be simply f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c349e7818a81214e0506e0848d894bf8
https://hdl.handle.net/10453/166342
https://hdl.handle.net/10453/166342
Autor:
Chengnan Yan, Yibin Wang, Yan Zou, Xinhong Sun, Dongya Zhang, Bingyang Shi, Jia Li, Meng Zheng, Roger S. Chung, Yanjie Liu
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 32(24)
Small interfering RNA (siRNA) has been considered as a highly promising therapeutic agent for human cancer treatment including glioblastoma (GBM), which is a fatal disease without effective therapy methods. However, siRNA-based GBM therapy is serious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce516fc9ed2e98d5cf94ee446304d09
https://pubmed.ncbi.nlm.nih.gov/32374446
https://pubmed.ncbi.nlm.nih.gov/32374446
Publikováno v:
2006 6th World Congress on Intelligent Control & Automation; 2006, p7730-7733, 4p